Skip to main content
OpenTrials
Completed

NCT Number: NCT01243255

Polish Survey on the Efficacy of the Hypercholesterolemia Treatment

The purpose of the survey is to evaluate the efficacy of treatment of hypercholesterolemia in Polish patients who are currently on lipid- lowering pharmacological therapy . Efficient treatment is defined as achievement of the LDL cholesterol level goals according to the European Society of Cardiology 2007 guidlines.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypercholesterolemia Dyslipidemias Hyperlipidemias Lipid Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients on lipid lowering drug treatment
  • Lipid lowering drug treatment lasting at least 3 months
  • No lipid lowering drug/dose change for a minimum 6 weeks prior to enrolment to the study

Exclusion criteria

  • Lack of patient's signed informed consent form
  • Lack of the blood sample taken for lipid profile and glucose within 10 days before or after assessment of the patient

Treatment and study plan

Primary outcomes

  1. establish the proportion of patients on lipid lowering pharmacological treatment reaching the LDL-C goals according to ESC 2007 guidelines in general.

    Time frame: whole study procedure takes place during the one, single patient's visit

Secondary outcomes

  1. establish the proportion of patients on lipid lowering pharmacological treatment in primary prevention, reaching the LDL-C goals according to ESC 2007 guidelines for this sub-population

    Time frame: whole study procedure takes place during the one, single patient's visit

  2. establish the proportion of patients on lipid lowering pharmacological treatment in secondary prevention, reaching the LDL-C goals according to ESC 2007 guidelines for this sub-population

    Time frame: whole study procedure takes place during the one, single patient's visit

  3. identify determinants (patient and physician characteristics) for undertreatment of hypercholesterolemia.

    Time frame: whole study procedure takes place during the one, single patient's visit

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Centralized Pan-European Survey on the Undertreatment of Hypercholesterolemia. Polish Survey on the Efficacy of the Hypercholesterolemia Treatment

Acronym: CEPHEUS

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Nov 18, 2010
Registry last updated
Apr 4, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.